Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Share Options

16 Mar 2018 07:00

RNS Number : 9200H
Falanx Group Limited
16 March 2018
 

Falanx Group Limited

("Falanx" or "the Company")

Grant of Share Options

Falanx Group Ltd announces the grant of 15,000,000 share options to the Directors and 9,150,000 share options to other management and employees (together the "Share Options").

The Company considers it important to incentivise employees and Directors through share incentive arrangements and to align them with shareholders to create long term value.

Options under this plan are granted with a strike price of 5p each, this is approximately 11% higher than the mid-market closing price of 4.5p on 15 March 2018. The option scheme is structured so that there are only returns for participants where the share price has very significantly increased from the current levels. Individual Director grants are set out below:

Individual Director Option Grants

 

Current Share Options

New Grant

Enlarged Share Options

Mike Read

-

5,000,000

5,000,000

Ian Selby

-

5,000,000

5,000,000

John Blamire

500,000

4,500,000

5,000,000

Emma Shaw

750,000

500,000

1,250,000

 

Vesting Criteria

These options vest in three tranches: the first tranche when the share price reaches 7.5p (25%), the second tranche when the share price reaches 10p (25%) and the third tranche when the share price reaches 12.5p (50%). The Share Options only vest if the average share price has reached the relevant threshold level for a period of three months, save for the event of a change of control in the Company, in which case they will vest in full. Based on the mid-market closing price of 4.5p, there is no gain at all unless the share price increases by 66% and full gains are not achieved until a gain of 178% has been achieved.

A further option grant is planned soon for staff in the recently acquired First Base business.

Executive Directors are issued share options under the EMI Scheme and Non-Executive Directors and (any other ineligible participants) under an unapproved scheme, which has the same rules as the EMI Scheme but without the relevant tax concessions. The Share Options have an exercise period of 10 years from grant under the rules of the EMI Scheme.

The above grant of 24,150,000 options represents approximately 9% of the share capital following the admission of the shares announced on 6 March 2018.

   

 

Falanx Group Limited

Mike Read, Chairman and CEO

John Blamire, COO

Ian Selby, CFO

 

www.falanx.com

 

 

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis / James Keeshan

+44 (0) 203 368 3551

 

 

 

 

 

Turner Pope Investments (TPI) Ltd

Broker

Andy Thacker

 

IFC Advisory Ltd

Financial PR & IR

Graham Herring

Miles Nolan

Zach Cohen

+44 (0) 203 621 4120

 

 

 

+44 (0) 203 934 6630

     

 

Falanx Group Limited, is a global intelligence and cyber defence provider working with blue chip and government clients. The Group listed on AIM in June 2013 under ticker FLX For more information: http://www.falanx.com/ 

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1. Mike Read

2. Ian Selby

3. John Blamire

4. Emma Shaw

2

Reason for the notification

a)

Position/status

Directors and PDMRs of the Company

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Falanx Group Limited

b)

LEI

213800YO4F9CUQLALV19

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Options over Ordinary Shares

 

 

 

ISIN: VGG3338A1075

b)

Nature of the transaction

Grant of nil-cost options

 

c)

Price(s) and volume(s)

 

Price: 5p

Volume

1. 5,000,000

2. 5,000,000

3. 4,500,000

4. 500,000

 

5.

d)

Aggregated information

 

- volume: 15,000,000

- Price: 5p

e)

Date of the transaction

15 March 20018

f)

Place of the transaction

Not on a trading venue

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHFKPDNNBKBKND
Date   Source Headline
21st Dec 201812:45 pmRNSDirector/PDMR Shareholding
3rd Dec 20187:00 amRNSIssue of Equity Update - Replacement
30th Nov 20186:25 pmRNSIssue of Equity Update
30th Nov 201811:38 amRNSTotal Voting Rights
26th Nov 20181:06 pmRNSTR-1: notification of major holdings
20th Nov 20187:00 amRNSTR-1: notification of major holdings
16th Nov 20187:51 amRNSTR-1: notification of major holdings
16th Nov 20187:50 amRNSTR-1: notification of major holdings
14th Nov 20187:42 amRNSIssue of Equity
14th Nov 20187:00 amRNSINTERIM RESULTS for 6 Months to 30 September 2018
16th Oct 20187:00 amRNSFALANX AND SOLARWINDS PARTNERSHIP UPDATE
19th Sep 20187:00 amRNSInvestor Event
19th Sep 20187:00 amRNSSOLARWINDS MSP APPOINTS FALANX
21st Aug 20189:45 amRNSDirector / PDMR Shareholding
15th Aug 201811:35 amRNSDirector / PDMR Shareholding
15th Aug 201811:22 amRNSDirector / PDMR Shareholding
14th Aug 20184:40 pmRNSSecond Price Monitoring Extn
14th Aug 20184:35 pmRNSPrice Monitoring Extension
14th Aug 20187:00 amRNSAnnual Results for the Year-Ended 31 March 2018
31st Jul 20187:00 amRNSContract Announcement
17th Jul 20187:00 amRNSACQUISITION OF SECURESTORM LIMITED
10th Jul 20187:00 amRNSNotice of Results
16th May 20187:00 amRNSCONTRACT WINS AND TECHNOLOGY DEVELOPMENT
18th Apr 20187:00 amRNSCYBER SECURITY OPERATIONAL UPDATE
21st Mar 20182:38 pmRNSTR-1:Notification of Major Holdings
16th Mar 20187:00 amRNSGrant of Share Options
12th Mar 20187:00 amRNSManagement Structure and Directorate Change
6th Mar 20188:45 amRNSResult of Accelerated Bookbuild
6th Mar 20187:00 amRNSProposed ABB and Conditional Acquisition
2nd Mar 201811:57 amRNSStatement regarding Broker
7th Feb 20187:00 amRNSContract Wins
15th Jan 20188:37 amRNSContract Win and Directorate Change
20th Dec 20177:00 amRNSContract Win and Managed Services Update
20th Nov 20178:41 amRNSTR-1: Notification of of major holdings
17th Nov 20177:00 amRNSDirector/PDMR Shareholding
15th Nov 20177:00 amRNSInterim Results
14th Nov 20177:00 amRNSDirectorate Change & Notice of Results
18th Sep 20177:00 amRNSNon Regulatory - Cyber Partnership
13th Sep 20177:00 amRNSAppointment of Joint Broker
13th Sep 20177:00 amRNSProprietary MidGARD Platform launch
11th Sep 20177:00 amRNSAcquisition and Appointment of CTO
5th Sep 20177:00 amRNSOperational Update
21st Jul 20174:58 pmRNSTR-1: Notification of Major Interest in Shares
20th Jul 20171:31 pmRNSDirector/PDMR Shareholding
18th Jul 20177:00 amRNSManaging Director appointed for Stirling Assynt
10th Jul 20177:00 amRNSAnnual Results for the Year-Ended 31 March 2017
5th Jul 20177:31 amRNSAcquisition of Cloudified Ltd
23rd Jun 20178:36 amRNSNotice of Results
8th Jun 20171:50 pmRNSInvestor Evening
6th Jun 20177:00 amRNSAppointment of Joint-Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.